Patents by Inventor Yasushi Hattori
Yasushi Hattori has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11961631Abstract: A connection structure of a superconducting layer according to an embodiment includes a first superconducting layer, a second superconducting layer, and a connection layer provided between the first superconducting layer and the second superconducting layer and including a first substance containing a rare earth element, barium, copper, and oxygen and a second substance containing a metal element, in which a first region per unit area at a first interface between the first superconducting layer and the connection layer is 1% or more and 50% or less where the second substance and the first superconducting layer are in contact with each other, and a second region per unit area at a second interface between the second superconducting layer and the connection layer is 1% or more and 50% or less where the second substance and the second superconducting layer are in contact with each other.Type: GrantFiled: March 8, 2022Date of Patent: April 16, 2024Assignee: Kabushiki Kaisha ToshibaInventors: Masaya Hagiwara, Tomoko Eguchi, Keiko Albessard, Yasushi Hattori
-
Publication number: 20240107898Abstract: A superconducting layer joint structure of embodiments includes: a first superconducting layer; a second superconducting layer; and a joint layer provided between the first superconducting layer and the second superconducting layer and containing a plurality of crystal particles containing a rare earth element (RE), barium (Ba), copper (Cu), and oxygen (O). The plurality of crystal particles includes at least one first particle. The at least one first particle has a first inner region and a first outer region. The first inner region is disposed inside the first superconducting layer. The first outer region is disposed outside the first superconducting layer.Type: ApplicationFiled: March 8, 2023Publication date: March 28, 2024Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Tomoko EGUCHI, Yasushi HATTORI, Masaya HAGIWARA, Keiko ALBESSARD
-
Patent number: 11855400Abstract: A connection structure of a superconducting layer of an embodiment incudes a first superconducting member including a first superconducting layer, and extends in a first direction, a second superconducting member including a second superconducting layer facing the first superconducting layer, and extends in the first direction, the second superconducting member having a first region, a second region, and a third region which is separated in the second direction from the second region, and a connection layer that contains a rare earth element (RE), barium (Ba), copper (Cu), and oxygen (O), and connects the first superconducting layer and the second superconducting layer. The first superconducting layer is present in a third direction between the second region and the third region, the third direction being perpendicular to the first direction and perpendicular to the second direction.Type: GrantFiled: September 3, 2021Date of Patent: December 26, 2023Assignees: Kabushiki Kaisha Toshiba, Toshiba Energy Systems & Solutions CorporationInventors: Yasushi Hattori, Tomoko Eguchi, Masaya Hagiwara, Keiko Albessard
-
Publication number: 20230268099Abstract: A connection structure for a superconducting layer according to an embodiment includes a first superconducting layer, a second superconducting layer, and a connection layer between the first superconducting layer and the second superconducting layer, the connection layer including crystal particles containing a rare earth element, barium, copper, and oxygen, the crystal particles having a major diameter distribution including a trimodal distribution. The trimodal distribution has first, second, and third distributions in which major diameter become small in this order. The aspect ratios of the crystal particles included in the first distribution and the second distribution include a bimodal distribution. The median value of the major diameters of the crystal particles included in the distribution on a higher aspect ratio side in the bimodal distribution is greater than the median value of the major diameters of the crystal particles included in the distribution on a lower aspect ratio side.Type: ApplicationFiled: September 2, 2022Publication date: August 24, 2023Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Yasushi HATTORI, Tomoko EGUCHI, Masaya HAGIWARA, Keiko ALBESSARD
-
Patent number: 11729907Abstract: A structure according to the embodiment includes a first crystal grain, a second crystal grain, and a first region. The first crystal grain includes silicon nitride. The second crystal grain includes a first element selected from a first group consisting of scandium, yttrium, lanthanum, cerium, praseodymium, neodymium, promethium, samarium, europium, gadolinium, terbium, dysprosium, holmium, erbium, thulium, ytterbium, lutetium, aluminum, chromium, zirconium, magnesium, zinc, titanium, gallium, beryllium, calcium, strontium, barium, hafnium, vanadium, niobium, tantalum, tungsten, iron, cobalt, nickel, and copper, and oxygen. The first region includes an oxide of the first element.Type: GrantFiled: February 5, 2021Date of Patent: August 15, 2023Assignee: KABUSHIKI KAISHA TOSHIBAInventors: Koichi Harada, Yasuhiro Goto, Kenji Essaki, Yasushi Hattori, Maki Yonetsu
-
Patent number: 11655241Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: GrantFiled: June 27, 2019Date of Patent: May 23, 2023Assignee: Takeda Pharmaceutical Company LimitedInventors: Tsuneo Oda, Yoshiteru Ito, Tohru Miyazaki, Kohei Takeuchi, Norihito Tokunaga, Yasutaka Hoashi, Yasushi Hattori, Keisuke Imamura, Yuichi Kajita, Yuhei Miyanohana, Takahiro Sugimoto, Tatsuki Koike, Dilhumar Uyghur
-
Publication number: 20230085118Abstract: A connection structure of a superconducting layer according to an embodiment includes a first superconducting layer, a second superconducting layer, and a connection layer provided between the first superconducting layer and the second superconducting layer and including a first substance containing a rare earth element, barium, copper, and oxygen and a second substance containing a metal element, in which a first region per unit area at a first interface between the first superconducting layer and the connection layer is 1% or more and 50% or less where the second substance and the first superconducting layer are in contact with each other, and a second region per unit area at a second interface between the second superconducting layer and the connection layer is 1% or more and 50% or less where the second substance and the second superconducting layer are in contact with each other.Type: ApplicationFiled: March 8, 2022Publication date: March 16, 2023Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Masaya HAGIWARA, Tomoko EGUCHI, Keiko ALBESSARD, Yasushi HATTORI
-
Publication number: 20230063805Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: ApplicationFiled: June 22, 2022Publication date: March 2, 2023Inventors: Yuichi KAJITA, Yuhei MIYANOHANA, Tatsuki KOIKE, Kohei TAKEUCHI, Yoshiteru ITO, Norihito TOKUNAGA, Takahiro SUGIMOTO, Tohru MIYAZAKI, Tsuneo ODA, Yasutaka HOASHI, Yasushi HATTORI, Keisuke IMAMURA
-
Publication number: 20230040770Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: ApplicationFiled: January 30, 2020Publication date: February 9, 2023Inventors: Yasushi HATTORI, Yuhei MIYANOHANA, Tatsuki KAJITA, Tatsuki KOIKE, Yasutaka HOASHI, Norihito TOKUNAGA, Alexander Martin PAWLICZEK, Tsuneo ODA, Tohru MIYAZAKI, Yoshiteru ITO, Kohei TAKEUCHI, Keisuke IMAMURA, Takahiro SUGIMOTO
-
Publication number: 20230037557Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: ApplicationFiled: November 26, 2020Publication date: February 9, 2023Inventors: Yoshiteru ITO, Yuhei MIYANOHANA, Yuichi KAJITA, Yasutaka HOASHI, Yasushi HATTORI, Tatsuki KOIKE, Norihito TOKUNAGA, Eiji KIMURA, Alexander Martin PAWLICZEK, Marilena PIRA, Javier MIGUELEZ-RAMOS
-
Publication number: 20230042358Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: ApplicationFiled: December 11, 2019Publication date: February 9, 2023Applicant: Takeda Pharmaceutical Company LimitedInventors: Yuhei MIYANOHANA, Yuichi KAJITA, Tatsuki KOIKE, Yasutaka HOASHI, Yasushi HATTORI, Norihito TOKUNAGA, Tsuneo ODA, Tohru MIYAZAKI, Dilhumar UYGHUR, Yoshiteru ITO, Kohei TAKEUCHI, Keisuke IMAMURA, Takahiro SUGIMOTO, Koichiro FUKUDA, Yasuhisa KOHARA, Rei OKAMOTO, Taiichi OHRA, Naoki MIYAMOTO, Jun CHIBA, Yoshito TERAO, Masanori KAWASAKI
-
Publication number: 20230030881Abstract: A connection structure of conductive layers according to an embodiment includes: a first conductive member including a first conductive layer and a first substrate, the first conductive member extending in a first direction, the first conductive member curved in the first direction such that the first conductive layer side is convex; a second conductive member including a second conductive layer and a second substrate, the second conductive member extending in the first direction, the second conductive member curved in the first direction such that the second conductive layer side is convex; a third conductive member including a third conductive layer and a third substrate, the third conductive member extending in the first direction; a first connection layer between a the first conductive layer and the third conductive layer, the first connection layer having varying thickness; and a second connection layer between the second conductive layer and the third conductive layer, the second connection layer havingType: ApplicationFiled: March 8, 2022Publication date: February 2, 2023Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Yasushi HATTORI, Tomoko EGUCHI, Masaya HAGIWARA, Keiko ALBESSARD
-
Publication number: 20220302609Abstract: A connection structure of a superconducting layer of an embodiment incudes a first superconducting member including a first superconducting layer, and extends in a first direction, a second superconducting member including a second superconducting layer facing the first superconducting layer, and extends in the first direction, the second superconducting member having a first region, a second region, and a third region which is separated in the second direction from the second region, and a connection layer that contains a rare earth element (RE), barium (Ba), copper (Cu), and oxygen (O), and connects the first superconducting layer and the second superconducting layer. The first superconducting layer is present in a third direction between the second region and the third region, the third direction being perpendicular to the first direction and perpendicular to the second direction.Type: ApplicationFiled: September 3, 2021Publication date: September 22, 2022Applicants: KABUSHIKI KAISHA TOSHIBA, TOSHIBA ENERGY SYSTEMS & SOLUTIONS CORPORATIONInventors: Yasushi HATTORI, Tomoko EGUCHI, Masaya HAGIWARA, Keiko ALBESSARD
-
Patent number: 11440883Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: GrantFiled: March 6, 2020Date of Patent: September 13, 2022Assignee: Takeda Pharmaceutical Company LimitedInventors: Yuichi Kajita, Yuhei Miyanohana, Tatsuki Koike, Kohei Takeuchi, Yoshiteru Ito, Norihito Tokunaga, Takahiro Sugimoto, Tohru Miyazaki, Tsuneo Oda, Yasutaka Hoashi, Yasushi Hattori, Keisuke Imamura
-
Publication number: 20220199887Abstract: A connection structure for a superconducting layer according to an embodiment includes a first superconducting layer; a second superconducting layer; and a connection layer disposed between the first superconducting layer and the second superconducting layer, the connection layer including crystal grains containing a rare earth element (RE), barium (Ba), copper (Cu), and oxygen (O), the crystal grains having a grain size distribution including a bimodal distribution. The bimodal distribution includes a first distribution including a first peak and a second distribution including a second peak. A first grain size corresponding to the first peak is larger than a second grain size corresponding to the second peak. Among the crystal grains, crystal grains having a grain size corresponding to the first distribution include a crystal grain having a plate shape or a flat shape.Type: ApplicationFiled: March 8, 2022Publication date: June 23, 2022Applicants: KABUSHIKI KAISHA TOSHIBA, TOSHIBA ENERGY SYSTEMS & SOLUTIONS CORPORATIONInventors: Masaya Hagiwara, Tomoko Eguchi, Keiko Albessard, Yasushi Hattori
-
Patent number: 11355416Abstract: A structure includes: a ? silicon nitride crystal phase; and a Y2MgSi2O5N crystal phase. The structure gives a X-ray diffraction pattern by a ?-2? method, the pattern having a ratio of a peak intensity of a (22-1) plane of the Y2MgSi2O5N crystal phase to a peak intensity of a (200) plane of the ? silicon nitride crystal phase, the peak intensity of the (200) plane being determined at a position of 2?=27.0±1°, the peak intensity of the (22-1) plane being determined at a position of 2?=30.3±1°, and the ratio being 0.001 or more and 0.01 or less.Type: GrantFiled: August 31, 2020Date of Patent: June 7, 2022Assignee: KABUSHIKI KAISHA TOSHIBAInventors: Yumi Fukuda, Koichi Harada, Yasushi Hattori, Maki Yonetsu, Kenji Essaki, Keiko Albessard, Yasuhiro Goto
-
Patent number: 11319286Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof, has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: GrantFiled: August 2, 2018Date of Patent: May 3, 2022Assignee: Takeda Pharmaceutical Company LimitedInventors: Tatsuhiko Fujimoto, Kentaro Rikimaru, Koichiro Fukuda, Hiromichi Sugimoto, Takahiro Matsumoto, Yuichi Kajita, Satoshi Mikami, Yuhei Miyanohana, Tatsuki Koike, Masaki Daini, Masaki Ogino, Kohei Takeuchi, Tohru Miyazaki, Yoshiteru Ito, Norihito Tokunaga, Takahiro Sugimoto, Tsuneo Oda, Yasutaka Hoashi, Yasushi Hattori, Keisuke Imamura
-
Publication number: 20220017514Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: ApplicationFiled: December 11, 2019Publication date: January 20, 2022Applicant: Takeda Pharmaceutical Company LimitedInventors: Yuichi KAJITA, Yuhei MIYANOHANA, Tatsuki KOIKE, Yasutaka HOASHI, Yasushi HATTORI, Norihito TOKUNAGA, Tsuneo ODA, Tohru MIYAZAKI, Dilhumar UYGHUR, Yoshiteru ITO, Kohei TAKEUCHI, Keisuke IMAMURA, Takahiro SUGIMOTO, Koichiro FUKUDA, Yasuhisa KOHARA, Rei OKAMOTO, Taiichi OHRA, Naoki MIYAMOTO, Yoshito TERAO, Masanori KAWASAKI
-
Publication number: 20210296205Abstract: A structure includes: a ? silicon nitride crystal phase; and a Y2MgSi2O5N crystal phase. The structure gives a X-ray diffraction pattern by a ?-2? method, the pattern having a ratio of a peak intensity of a (22-1) plane of the Y2MgSi2O5N crystal phase to a peak intensity of a (200) plane of the ? silicon nitride crystal phase, the peak intensity of the (200) plane being determined at a position of 2?=27.0±1°, the peak intensity of the (22-1) plane being determined at a position of 2?=30.3±1°, and the ratio being 0.001 or more and 0.01 or less.Type: ApplicationFiled: August 31, 2020Publication date: September 23, 2021Applicant: KABUSHIKI KAISHA TOSHIBAInventors: Yumi FUKUDA, Koichi HARADA, Yasushi HATTORI, Maki YONETSU, Kenji ESSAKI, Keiko ALBESSARD, Yasuhiro GOTO
-
Publication number: 20210276949Abstract: The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.Type: ApplicationFiled: April 23, 2021Publication date: September 9, 2021Applicant: Takeda Pharmaceutical Company LimitedInventors: Yasushi HATTORI, Yuhei MIYANOHANA, Yuichi KAJITA, Tatsuki KOIKE, Yasutaka HOASHI, Norihito TOKUNAGA, Alexander Martin PAWLICZEK, Tsuneo ODA, Tohru MIYAZAKI, Yoshiteru ITO, Kohei TAKEUCHI, Keisuke IMAMURA, Takahiro SUGIMOTO